Huai Zheng Peng
Director Ejecutivo en A&B (HK) Co. Ltd. .
Perfil
Huai Zheng Peng is currently the Chief Executive Officer at A&B (HK) Co. Ltd., Director at Neurelis, Inc., Director at Blueberry Therapeutics Ltd., Director at China Medical Venture Investment Hk Ltd., and Non-Executive Director at Cambridge United China Collaborations Ltd.
Previously, he held positions such as Director-Corporate Finance & Head-Life Sciences at Seymour Pierce Ltd., Non-Executive Director at China Medstar Ltd., Independent Director at Helius Medical Technologies, Inc., and Non-Executive Director at Faron Pharmaceuticals Oy, Navamedic ASA, Destiny Pharma Plc, Biodexa Pharmaceuticals Plc, and Acticor Biotech SAS.
He was also an Independent Non-Executive Director & GM at China Medical System Holdings Ltd.
and a Partner at Northland Bancorp, Inc. Additionally, he worked as a Senior Manager at Reabourne Technology Investment Management Ltd.
and as a Portfolio Manager at Close Asset Management (UK) Ltd.
Dr. Peng received his undergraduate and graduate degrees from Hunan University of Chinese Medicine and his doctorate from UCL Medical School.
Cargos activos de Huai Zheng Peng
Empresas | Cargo | Inicio |
---|---|---|
Blueberry Therapeutics Ltd.
Blueberry Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Blueberry Therapeutics Ltd. engages in the development of innovative medicines. It offers nanomedicine, anti infection and anti microbial, anti inflammatory bowel diseases, acne, dermatitis and wound medicines. The company was founded by John Ridden and Mike Davies and is headquartered in Macclesfield, the United Kingdom. | Director/Miembro de la Junta | - |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | Director/Miembro de la Junta | - |
A&B (HK) Co. Ltd.
A&B (HK) Co. Ltd. Electronic Equipment/InstrumentsElectronic Technology A & B (HK) Co. Ltd. is a Chinese company that manufactures and distributes portable neuro-modulation stimulator devices. The private company is based in Hong Kong, Hong Kong. The CEO of the company is Huai Zheng Peng. | Director Ejecutivo | - |
Cambridge United China Collaborations Ltd. | Director/Miembro de la Junta | - |
China Medical Venture Investment Hk Ltd. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Huai Zheng Peng.
Empresas | Cargo | Fin |
---|---|---|
DESTINY PHARMA PLC | Director/Miembro de la Junta | 01/06/2022 |
HELIUS MEDICAL TECHNOLOGIES, INC. | Director/Miembro de la Junta | 01/05/2020 |
BIODEXA PHARMACEUTICALS PLC | Director/Miembro de la Junta | 31/03/2020 |
Northland Bancorp, Inc.
Northland Bancorp, Inc. Investment ManagersFinance Northland Bancorp, Inc. is a private equity firm located in Calgary, Alberta | Corporate Officer/Principal | 01/01/2012 |
░░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
Formación de Huai Zheng Peng.
UCL Medical School | Doctorate Degree |
Hunan University of Chinese Medicine | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 7 |
---|---|
CHINA MEDICAL SYSTEM HOLDINGS LIMITED | Health Technology |
FARON PHARMACEUTICALS OY | Health Technology |
HELIUS MEDICAL TECHNOLOGIES, INC. | Health Technology |
NAVAMEDIC ASA | Distribution Services |
DESTINY PHARMA PLC | Health Technology |
BIODEXA PHARMACEUTICALS PLC | Health Technology |
ACTICOR BIOTECH SAS | Health Technology |
Empresas privadas | 10 |
---|---|
Close Asset Management (UK) Ltd.
Close Asset Management (UK) Ltd. Investment ManagersFinance Close Asset Management (UK) Ltd., doing business as Close Brothers Asset Management (CBAM), is an investment management firm headquartered in London, UK. The firm is a subsidiary of Close Asset Management Holdings Ltd., itself a subsidiary of Close Brothers Group Plc (LON: CBG). The firm was formerly known as Close Investments Ltd. in 1994 and changed into their current name when Close Brothers Investment, Close Investment, Close Finsbury Asset Management, and Reabourne Technology Investment Management were reorganized into a single legal entity in 2009. CBAM provides a wide variety of financial advisory and investment management services to UK and international intermediaries, private individuals, and institutions such as pension funds. They also manage discretionary portfolios as well as a diverse range of investment products. | Finance |
China Medstar Ltd.
China Medstar Ltd. Medical DistributorsDistribution Services China Medstar Ltd. supplies and leases radiotherapy equipment for cancer treatment. The company have sixteen operational centers, ten radiotherapy, two nuclear medicine examine (including ECT and PET-CT) and MR, and one HIFU and ophthalmic center. The company was established in 2003 and is headquartered in Beijing, China. | Distribution Services |
Seymour Pierce Ltd.
Seymour Pierce Ltd. Investment Banks/BrokersFinance Seymour Pierce Ltd. (SP) is an independent Great Britain-based brokerage firm which was established in 1998. SP advises growing privately-owned businesses and publicly quoted UK companies, with a focus on AIM-listed companies. They provide stockbroking, corporate finance, private equity and M&A advisory services and specialize in raising funds for small- and medium-sized UK companies, either facilitating private equity investing or issuing securities. The firm provides sellside analysis to asset managers in Great Britain and internationally, including fund managers, hedge funds and private equity firms. Their research covers a range of sectors including retail, real estate, healthcare, media and entertainment, resources, software, telecommunications, financials, business services and special situations. SP also advises private clients and provides administrative support. They manage equity portfolios on a discretionary basis and provide equity trading accounts, both advisory and execution-only. | Finance |
Northland Bancorp, Inc.
Northland Bancorp, Inc. Investment ManagersFinance Northland Bancorp, Inc. is a private equity firm located in Calgary, Alberta | Finance |
Reabourne Technology Investment Management Ltd. | |
Blueberry Therapeutics Ltd.
Blueberry Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Blueberry Therapeutics Ltd. engages in the development of innovative medicines. It offers nanomedicine, anti infection and anti microbial, anti inflammatory bowel diseases, acne, dermatitis and wound medicines. The company was founded by John Ridden and Mike Davies and is headquartered in Macclesfield, the United Kingdom. | Health Technology |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | Health Technology |
A&B (HK) Co. Ltd.
A&B (HK) Co. Ltd. Electronic Equipment/InstrumentsElectronic Technology A & B (HK) Co. Ltd. is a Chinese company that manufactures and distributes portable neuro-modulation stimulator devices. The private company is based in Hong Kong, Hong Kong. The CEO of the company is Huai Zheng Peng. | Electronic Technology |
Cambridge United China Collaborations Ltd. | |
China Medical Venture Investment Hk Ltd. |
- Bolsa de valores
- Insiders
- Huai Zheng Peng